Please log in to view this page
Username
Password
The investigators are looking for a better way to prevent cervical cancer. This study is comparing two different methods to...
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
Study of MDR TB Cases and Their Household Contacts: Operational Feasibility to Inform PHOENIx Trial Design
